Productive HIV Infection of Resting CD4+ T Cells: Role of Lymphoid Tissue Microenvironment and Effect of Immunomodulating Agents

AIDS Research and Human Retroviruses

Volumn 19, Issue 10, 2003, Pages 847-856

  Kinter, Audrey ^a   Moorthy, Anitha ^a   Jackson, Robert ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; KI 67 ANTIGEN; MYCOPHENOLIC ACID; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ADULT; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOMODULATION; LYMPHOID TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TONSIL; VIRUS INFECTION; VIRUS REPLICATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; TONSIL; VIRUS REPLICATION;

EID: 0242364699     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322493012     Document Type: Review

References (64)

1. Chun T-W, Finzi D, Margolick J, Chadwick K, Schwanz D, and Siliciano RP: In vitro fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency. Nat Med 1995;1: 1284-1290.
2. Chun T-W, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, et al.: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997;94:13193-13197.
3. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278: 1295-1300.
4. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA, et al.: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997;278: 1291-1295.
5. Pierson T, McArthur J, and Siliciano RF: Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000;18:665-708.
6. Blankson JN, Persaud D, and Siliciano RF: The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002;53:557-593.
7. Spina CA, Guatelli JC, and Richman DD: Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 1995;69: 2977-2988.
8. Chou CS, Ramilo O, and Vitetta ES: Highly purified CD25(-) resting T cells cannot be infected de novo with HIV-1. Proc Natl Acad Sci USA 1997;94:1361-1365.
9. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, and Chen IS: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 1990;61: 213-222.
10. Stevenson M, Stanwick TL, Dempsey MP, and Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990;9:1551-1560.
11. Chun T-W, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-188.
12. McCoig C, Van Dyke G, Chou CS, Picker LJ, Ramilo O, et al.: An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro. Proc Natl Acad Sci USA 1999;96:11482-11485.
13. Ho DD, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
14. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
15. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al.: Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999;286:1353-1357.
16. Zhu T, Muthui D, Holte S, Nickte D, Feng F, Brodie S, et al.: Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002;76: 707-716.
17. Scales D, Ni H, Shaheen F, Capodici J, Cannon G, and Weissman D: Nonproliferating bystander CD4(+) T cells lacking activation markers support HIV replication during immune activation. J Immunol 2001;166:6437-6443.
18. Unutmaz D, KewalRamani VN, Marmon S, and Littman DR: Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 1999;189:1735-1746.
19. Eckstein DA, Penn ML, Korin YD, Scripture-Adams DD, Zack JA, Kreisberg JF, et al.: HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 2001; 15:671-682.
20. Ostrowski MA, Chun T-W, Justement SJ, Motola I, Spinelli MA, Adelsberger J, et al.: Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999;73:6430-6435.
21. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, and Schuitemaker H: In vivo HIV-1 infection of CD45RA(+) CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 2000;97:1269-1274.
22. De Rosa SC, Herzenberg LA, and Roederer M: 11-Color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7:245-248.
23. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-358.
24. Fauci AS: Host factors in the pathogenesis of HIV disease. Antibiot Chemother 1996;48:4-12.
25. Cohen OJ, Pantaleo G, Lam GK, and Fauci AS: Studies on lymphoid tissue from HIV-infected individuals: Implications for the design of therapeutic strategies. Springer Semin Immunopathol 1997;18:305-322.
26. Fox CH and Cottler-Fox M: The pathobiology of HIV infection. Immunol Today 1992;13:353-356.
27. Burton GF, Keele BF, Ester JD, Thacker TC, and Gartner S: Follicular dendritic cell contributions to HIV pathogenesis. Semin Immunol 2002;14:275-278.
28. Poli G and Fauci AS: Role of cytokines in the pathogenesis of Human Immunodeficiency Virus infection. In: Human Cytokines: Their Role in Disease and Therapy (Aggarwal BB and Puri RK, eds.). Blackwell Science, Inc., Cambridge, MA, 1995, pp. 421-449.
29. Cohen OJ, Kinter A, and Fauci AS: Host factors in the pathogenesis of HIV disease. Immunol Rev 1997:159:31-48.
30. Kinter A, Arthos J, Cicala C, and Fauci AS: Chemokines, cytokines and HIV: A complex network of interactions that influence HIV pathogenesis. Immunol Rev 2000;177:88-98.
31. Alfano M and Poli G: Cytokine and chemokine based control of HIV infection and replication. Curr Pharm Des 2001;7:993-1013.
32. Nagira M, Sato A, Miki S, Imai T, and Yoshi O: Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissue. Virology 1999;264:422-426.
33. Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, et al.: CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4+ T cells: Role of signal transduction. Proc Natl Acad Sci USA 1998;95:11880-11885.
34. Tellier MC, Greco G, Klotman M, Mosoian A, Cara A, Arap W, et al.: Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4+ T lymphocytes. J Immunol 2000; 164:3236-3245.
35. Kotler DC, Gendelman HE, and Meltzer MS: Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol Lett 1991;30:219-227.
36. Lee B, Leslie G, Soilleux E, O'Doherty U, Balk S, Levroney E, et al.: cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J Virol 2001;75:12028-12038.
37. Glushakova S, Baibakov B, Margolis LB, and Zimmerberg I: Infection of human tonsil histocultures: A model for HIV pathogenesis. Nat Med 1995;1:1320-1322.
38. Allison AC, Kowalski WJ, Muller CD, and Eugui EM: Mechanisms of action of mycophenolic acid. Ann NY Acad Sci 1993; 696:63-87.
39. Yu CC, Woods AL, and Levison, DA: The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem J 1992;24: 121-131.
40. Waseem NH and Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990;96:121-129.
41. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
42. Mo H, Monard S, Pollack H, Ip J, Rochford G, Wu L, et al.: Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. AIDS Res Hum Retroviruses 1998;14:607-617.
43. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, et al.: Expression of chemokine receptors CXCR4 and CCR5 in HIV-infected and uninfected individuals. J Immunol 1998;161:3195-3201.
44. Gondois-Rey F, Grivel J-C, Biancotto A, Pion M, Vigne R, Margolis L, and Hirsch I: Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. AIDS 2002;16:1245-1249.
45. Fulcher D and Wong S: Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 1999;77:559-564.
46. Chapuis AG, Paolo Rizzardi G, D'Agostino C, Attinger A, Knabenhans C, Fleury S, et al.: Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000;6:762-768.
47. Aggarwal BB and Pocsik E: Cytokines: From clone to clinic. Arch Biochem Biophys 1992;292:335-359.
48. Weissman D, Daucher J, Barker T, Adelsberger J, Baseler M, and Fauci AS: Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses 1996;12:759-767.
49. Polacino PS, Pinchuk LM, Sidorenko SP, and Clark EA: Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J Med Primatol 1996;25:201-209.
50. Kinter AL, Umscheid CA, Arthos J, Cicala C, Lin Y, Jackson R, et al.: HIV envelope induces virus expression from resting CD4+ T cells from HIV-infected individuals in the absence of markers of cellular activation or apoptosis. J Immunol 2003;170:2449-2455.
51. 50a. Swingler S, Brichacek B, Jacque JM, et al. HIV-1 Nef intersects the macrophage CD4DL signaling pathway to promote resting-cell infection. Nature 2003;424:213-219.
52. Chun T-W, Engel D, Mizell SB, Ehler LA, and Fauci AS: Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 1998;188:83-91.
53. Ghose R, Liou L-Y, Herrmann CH, and Rice AP: Induction of TAK (cyclin T1/TEFb) in purified resting CD4+ T lymphocytes by combination of cytokines. J Virol 2001;75:11336-11343.
54. Devergne O, Peuchmaur M, Humbert M, Mavratil E, Leger-Ravet MB, Crevon MC, et al.: In vivo expression of IL-1β and IL-6 genes during viral infections in human. Eur Cytokine Net 1991;2:183-194.
55. Li Q, Gebhard K, Schacker T, Henry K, and Haase AT: The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J Virol 1997;71: 7080-7082.
56. Emilie D, Peuchmaur M, Maillot MC, Crevon MC, Brousse N, Delfraissy JF, et al.: Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990; 86:148-159.
57. Li G, Simm M, Potash MJ, and Volsky DJ: Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J Virol 1993;67:3969-3977.
58. Korin YD and Zack JA: Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 1998;72:3161-3168.
59. Tang H, Kuhen K, and Wong-Staal F: Lentivirus replication and regulation. Annu Rev Genet 1999;33:133-170.
60. Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, Margolick JB, et al.: Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J Virol 2000;74:7824-7833.
61. Sallusto F, Lenig D, Forster R, Lipp M, and Lazacecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-711.
62. Fauci AS, Pantaleo G, Stanley S, and Weissman D: Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996;124: 654-663.
63. Sleasman JW and Goodenow MM: HIV-1 infection. J Allergy Clin Immunol 2003;11:S582-592.
64. Chun TW, Justement JS, Lempicki RA, Yang J, Dennis G Jr, Hallahan CS, et al.: Gene expression and viral production in latently infected resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA 2003;100:1908-1913.